| Tertiary hospital | Total | Resistance prevalence (%) | |||
---|---|---|---|---|---|---|
MNRH | MRRH | MBRRH | KIU-TH | |||
Number of isolates | 82 | 24 | 87 | 34 | 227 | – |
AMP | 82 (100%) | 24 (100%) | 87 (100%) | 34 (100%) | 227 | 100 |
AMO | 82 (100%) | 24 (100%) | 85 (97.7%) | 34 (100%) | 225 | 99.1 |
SXT | 82 (97.6%) | 24 (100%) | 85 (97.7%) | 33 (97.1%) | 222 | 97.8 |
CXM | 81 (98.8%) | 24 (100%) | 86 (98.9%) | 34 (100%) | 225 | 99.1 |
TEM | 80 (97.6%) | 24 (100%) | 80 (92.0%) | 32 (94.1%) | 216 | 95.2 |
TPZ | 64 (78.1%) | 19 (79.2%) | 77 (88.5%) | 25 (73.5%) | 185 | 81.5 |
FOX | 52 (63.4%) | 14 (58.3%) | 48 (55.2%) | 15 (44.1%) | 129 | 56.8 |
FEP | 80 (97.6%) | 24 (100%) | 83 (95.4%) | 33 (97.1%) | 220 | 96.9 |
CRO | 82 (100%) | 23 (95.8%) | 86 (98.9%) | 34 (100%) | 225 | 99.1 |
CAZ | 82 (100%) | 24 (100%) | 86 (98.9%) | 34 (100%) | 226 | 99.6 |
CTX | 82 (100%) | 24 (100%) | 87 (100%) | 34 (100%) | 227 | 100 |
CIP | 30 (36.6%) | 9 (37.5%) | 30 (34.5%) | 13 (38.2%) | 82 | 36.1 |
ERT | 17 (20.7%) | 7 (29.2%) | 25 (28.7%) | 4 (11.8%) | 53 | 23.4 |
IMI | 11 (13.4%) | 3 (12.5%) | 7 (8.1%) | 4 (11.8%) | 25 | 11.0 |
MEM | 11 (13.4%) | 3 (12.5%) | 7 (8.1%) | 4 (11.8%) | 25 | 11.0 |